Myeloid cell
Prime and Boost Vaccination Elicit a Distinct Innate Myeloid Cell Immune Response
19
Control of Both Myeloid Cell Infiltration and Angiogenesis by CCR1 Promotes Liver Cancer Metastasis Development in Mice
11
Soluble factors regulated by epithelial-mesenchymal transition mediate tumour angiogenesis and myeloid cell recruitment.
34
Primary myeloid cell proteomics and transcriptomics: importance of β-tubulin isotypes for osteoclast function
53
en fr Myeloid cell subsets and microRNAs in juvenile arthritis Le rôle des cellules myéloïdes et microARNs dans l'arthrite juvénile
199
Intestinal epithelial cells instruct myeloid cell-mediated T-cell responses
85
Dendritic Cell Activating Receptor 1 (DCAR1) Associates With FcεRIγ and Is Expressed by Myeloid Cell Subsets in the Rat
13
Cell-to-Cell Spreading of HIV-1 in Myeloid Target Cells Escapes SAMHD1 Restriction
19
Regulatory myeloid cells: an underexplored continent in B-cell lymphomas
26
The Branching Point in Erythro-Myeloid Differentiation
28
Influence of alternative donor type on early survival after hematopoietic stem cell transplantation for acute myeloid leukemia lacking a sibling donor
47
Myeloid malignancies: mutations, models and management.
16
Apoptotic cells induce CD103 expression and immunoregulatory function in myeloid dendritic cell precursors through integrin αv and TGF-β activation
17
Dexamethasone in hyperleukocytic acute myeloid leukemia
12
Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia
12
Myeloid suppressor cell (MSC) deficiencies in non-obese diabetic (NOD) mice: a role in type 1 diabetes pathogenesis ?
2
Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia
16
The Hypothesis of the Human iNKT/Innate CD8(+) T-Cell Axis Applied to Cancer: Evidence for a Deficiency in Chronic Myeloid Leukemia
10
Natural killer-cell counts are associated with molecular relapse-free survival after imatinib discontinuation in chronic myeloid leukemia: the IMMUNOSTIM study
18
Practical management of Chronic Myeloid Leukemia in Belgium
17